The Applicant / Patent Holder "ノバルティスアーゲー" had 1 patent application filings in the most recent period (2023-01-01 to 2023-03-31). This is a significantly decreased of -12 filings (-92.3%) over 13 they had in the same period of the previous year (2022-01-01 to 2022-03-31).
The highest number of filings in 2014 with 263 cases, and their lowest number in 2022 with 71 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 623 cases in total) is 104, and the median is 100. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 104 patents |
Std Dev | 62.3 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 71 cases | -13.41 % |
2021 year | 82 cases | -30.5 % |
2020 year | 118 cases | -22.37 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ノバルティスアーゲー for the period of the last 10 years (2014-01-01 to 2024-11-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ノバルティスアーゲー, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The following foreign patent analysis reports have been found for ノバルティスアーゲー. The trends of patent filings of ノバルティスアーゲー for each country can be found by clicking on the Applicant/Patent Holder name next to each country.
Country | Applicant / Patent Holder |
---|---|
JP | ノバルティスアーゲー |
US | NOVARTIS AG |
EP | NOVARTIS AG |
PCT | NOVARTIS AG |
The changes in the number of patent filings of ノバルティスアーゲー over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
Patent landscaping is a visualization of the distribution of patent filings (application focus areas) for each technical keyword. Mountains and islands indicated by heatmap contours represent clusters of patent applications filed, and red areas on the heatmap indicate many patent filings relating to the keyword.
The patent landscape for ノバルティスアーゲー gives an intuitive understanding of what patent filings they have made and what technical position is to be established. By selecting filing year checkboxes and filtering, you can track their past filing trends (what technical area they have focused on).
By selecting applicant/patent holder checkboxes and filtering, you can visually grasp the technical areas of the filings for each applicant and the partnerships or alliances formed. Please use it as a guide for patent analysis and IP landscaping.
In addition, by visually representing the patent data in this manner, you can convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
In Patent Integration, you can check the specifics of a patent filing by clicking anywhere on the patent landscape screen. You can also quickly check the position of each applicant for each technical field by cross-referencing with other keywords and patent classifications. You can use it as a guide when considering hypotheses about each company's IP strategy on the IP Landscape. You can also use it for higher-grade intellectual property activities. It has reasonable pricing and a simple user interface that is easy for beginners to handle.
The following is a list of words (characteristic terms) often used in ノバルティスアーゲー patent applications. Characteristic terms with a higher importance are used in more patents/patent applications.
This patent analysis report was created for a patent search set of 1,545 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ノバルティスアーゲー are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Below is a patent map showing changes in the number of applications for JP patents of 0 companies in the same industry over the past 20 years.
The changes in the number of patents shared with ノバルティスアーゲー’s top coapplicants are shown below.
By searching for the top coapplicants, you can discover what companies ノバルティスアーゲー is partnered with to develop technologies and use this information for R&D and intellectual property strategies.
Also, by looking at the change in the number of filings, you can see what companies ノバルティスアーゲー conducted joint research with in the past, and check the history of ノバルティスアーゲー’s alliances, partnerships, and joint research and development.
If you want to search for more detailed information, you can use Patent Integration to quickly find out specifically what company they filed a joint application with and what invention it was for.
Among the top coapplicants, ザトラスティーズオブザユニバーシティオブペンシルバニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 84 cases, followed by デイナファーバーキャンサーインスティチュートインコーポレイテッド with 16 cases.
Name | Cases |
---|---|
ザトラスティーズオブザユニバーシティオブペンシルバニア | 84 cases |
デイナファーバーキャンサーインスティチュートインコーポレイテッド | 16 cases |
ゾーマテクノロジーリミテッド | 4 cases |
アステックス・セラピューティクス・リミテッド | 4 cases |
アイアールエム・リミテッド・ライアビリティ・カンパニー | 2 cases |
Below is a ranking of the number of JP patent applications by ノバルティスアーゲー’s top 6 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by ノバルティスアーゲー’s top 6 coapplicants over the last 20 years.
ノバルティスアーゲー filed 84 joint applications with ザトラスティーズオブザユニバーシティオブペンシルバニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 7 cases in total) is 1.2, and the median is 0. The coefficient of variation (standard deviation/mean) is 2.2, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 25 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 1.2 patents |
Std Dev | 2.6 |
COV | 2.2 |
Year | Cases | YOY |
---|---|---|
2018 year | 7 cases | -50.0 % |
2017 year | 14 cases | -36.4 % |
2016 year | 22 cases | -12.00 % |
ノバルティスアーゲー filed 4 joint applications with ゾーマテクノロジーリミテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 10 years (2013 to 2023, 6 cases in total) is 0.5, and the median is 0. The coefficient of variation (standard deviation/mean) is 1.8, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2014 with 3 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 0.5 patents |
Std Dev | 1.0 |
COV | 1.8 |
Year | Cases | YOY |
---|---|---|
2016 year | 1 cases | - |
2015 year | 0 cases | -100 % |
2014 year | 3 cases | +50.0 % |
ノバルティスアーゲー filed 16 joint applications with デイナファーバーキャンサーインスティチュートインコーポレイテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 4 cases in total) is 0.7, and the median is 0. The coefficient of variation (standard deviation/mean) is 1.7, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2015 with 7 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 0.7 patents |
Std Dev | 1.1 |
COV | 1.7 |
Year | Cases | YOY |
---|---|---|
2019 year | 1 cases | -66.7 % |
2018 year | 3 cases | - |
2017 year | 0 cases | -100 % |
ノバルティスアーゲー filed 4 joint applications with アステックス・セラピューティクス・リミテッド for the analysis period (2014 to 2024).
The mean of the number of filings over the last 10 years (2013 to 2023, 5 cases in total) is 0.5, and the median is 0. The coefficient of variation (standard deviation/mean) is 1.4, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 2 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 0.5 patents |
Std Dev | 0.7 |
COV | 1.4 |
Year | Cases | YOY |
---|---|---|
2018 year | 1 cases | - |
2017 year | 0 cases | -100 % |
2016 year | 2 cases | - |
The following shows JP patents held by ノバルティスアーゲー that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and ノバルティスアーゲー’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which ノバルティスアーゲー is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 7 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.1 times. The most recently Invalidation Trial patent is 特許6144713 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) , next is 特許6560289 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許6144713 | 新たな医薬組成物 | 2024-05-30 |
2 | 特許6560289 | 新たな医薬組成物 | 2024-05-30 |
3 | 特許7258832 | 多発性硬化症を処置するためのS1P受容体モジュレーター | 2024-05-08 |
4 | 特許4110140 | チロシンキナーゼの阻害剤 | 2023-08-10 |
5 | 特許7194153 | 新規製剤 | 2023-07-21 |
6 | 特許7185426 | S1P受容体モジュレーターの投与計画 | 2023-07-10 |
7 | 特許6931019 | 多発性硬化症を処置するためのS1P受容体モジュレーター | 2023-06-30 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 2 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6144713 "新たな医薬組成物" (1 times) , and the next most invalidation trial patent is 特許6560289 "新たな医薬組成物" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6144713 | 新たな医薬組成物 | 1 times |
2 | 特許6560289 | 新たな医薬組成物 | 1 times |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 4 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7244442 "注射装置および注射溶液移し替えシステム" (Opposition day 2023-09-22) , next is 特許7075521 "注射器" (Opposition day 2022-11-25) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7244442 | 注射装置および注射溶液移し替えシステム | 2023-09-22 |
2 | 特許7075521 | 注射器 | 2022-11-25 |
3 | 特許7042954 | 注射器 | 2022-09-28 |
4 | 特許7026991 | 注射器 | 2022-09-01 |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 5 patents Protest from third parties. The average number of Protest is 3.0 times. The most recently Protest patent is 特開2022-106763 "新規製剤" (Protest day 2023-12-21) , next is 特開2023-098949 "多発性硬化症を処置するためのS1P受容体モジュレーター" (Protest day 2023-08-28) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2022-106763 | 新規製剤 | 2023-12-21 |
2 | 特開2023-098949 | 多発性硬化症を処置するためのS1P受容体モジュレーター | 2023-08-28 |
3 | 特開2023-093482 | S1P受容体モジュレーターの投与計画 | 2023-08-28 |
4 | 特開2022-081491 | 注射器 | 2023-01-11 |
5 | 特開2021-184827 | 注射器 | 2022-10-28 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 3 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.3. The most protest patent is 特表2018-525389 "眼障害を治療する方法" (2 times) , and the next most protest patent is 特許6298034 "経皮吸収治療システム" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特表2018-525389 | 眼障害を治療する方法 | 2 times |
2 | 特許6298034 | 経皮吸収治療システム | 1 times |
3 | 特許6778175 | 脂質ナノ粒子ホスト中に核酸を封入する方法 | 1 times |
In the last 3 years (2021-12-01 ~ 2024-11-30), there were 41 patents Inspection from third parties. The average number of Inspection is 2.0 times. The most recently Inspection patent is 特開2020-189881 "RNA送達に有利なpKa値を有する脂質を含むリポソーム" (Inspection day 2024-10-11) , next is 特開2019-006777 "RNA送達に有利なpKa値を有する脂質を含むリポソーム" (Inspection day 2024-10-11) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特開2020-189881 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
2 | 特開2019-006777 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
3 | 特表2013-537518 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
4 | 特開2017-043626 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-11 |
5 | 特許6061849 | 自己複製RNA分子についてのビリオン様送達粒子 | 2024-10-10 |
6 | 特許5911870 | 免疫原をコードするRNAの送達のためのPEG化リポソーム | 2024-10-10 |
7 | 特許5940064 | 低用量のRNAを用いた大型哺乳動物の免疫化 | 2024-10-10 |
8 | 特許7531561 | RNA送達に有利なpKa値を有する脂質を含むリポソーム | 2024-10-10 |
9 | 特許7592743 | LNP023の結晶形態 | 2024-08-27 |
10 | 特許6144713 | 新たな医薬組成物 | 2024-06-10 |
11 | 特許6560289 | 新たな医薬組成物 | 2024-06-10 |
12 | 特許6097888 | 新規使用 | 2024-05-21 |
13 | 特許6931019 | 多発性硬化症を処置するためのS1P受容体モジュレーター | 2024-05-15 |
14 | 特許7185426 | S1P受容体モジュレーターの投与計画 | 2024-05-15 |
15 | 特許7258832 | 多発性硬化症を処置するためのS1P受容体モジュレーター | 2024-05-15 |
16 | 特開2022-058771 | 放出が改良された1-[(3-ヒドロキシ-アダマント-1-イルアミノ)-アセチル]-ピロリジン-2(S)-カルボニトリル製剤 | 2024-04-12 |
17 | 特許7436363 | 流体送達アライメントシステム | 2024-02-06 |
18 | 特許7431851 | 複数回投与の眼液送達システム | 2024-02-01 |
19 | 特開2022-106763 | 新規製剤 | 2024-01-19 |
20 | 特許6598985 | 新規の使用 | 2024-01-09 |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 39 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.4. The most inspection patent is 特許6298034 "経皮吸収治療システム" (5 times) , and the next most inspection patent is 特許6144713 "新たな医薬組成物" (4 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6298034 | 経皮吸収治療システム | 5 times |
2 | 特許6144713 | 新たな医薬組成物 | 4 times |
3 | 特許5798269 | 薬物高含量錠剤 | 4 times |
4 | 特開2018-035160 | 有機化合物 | 2 times |
5 | 特表2020-525483 | 抗TIM−3抗体のための投与レジメンおよびその使用 | 2 times |
Of the patent applications filed in the last 10 years (2014-12-01 to 2024-11-30), 210 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.6. The most cited patent is 特許6534389 "SHP2の活性を阻害するためのN−アザスピロシクロアルカン置換N−ヘテロアリール化合物および組成物" (23 times) , and the next most cited patent is 特許6779785 "ヒトメソテリンキメラ抗原受容体およびその使用" (20 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6534389 | SHP2の活性を阻害するためのN−アザスピロシクロアルカン置換N−ヘテロアリール化合物および組成物 | 23 times |
2 | 特許6779785 | ヒトメソテリンキメラ抗原受容体およびその使用 | 20 times |
3 | 特許7054622 | ヒト化抗BCMAキメラ抗原受容体を使用した癌の処置 | 18 times |
4 | 特表2017-513818 | キメラ抗原受容体を使用する癌の処置 | 16 times |
5 | 特許6473457 | SHP2の活性を阻害するための1−(トリアジン−3−イル/ピリダジン−3−イル)−ピペリジン/ピペラジン誘導体およびその組成物 | 15 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International